News

Overview of STMicroelectronics' Recent Share Repurchase Activity

Overview of STMicroelectronics' Recent Share Repurchase Activity

STMicroelectronics Provides Update on Share Repurchase Program

AMSTERDAM – STMicroelectronics N.V. (the “Company”), a prominent player in the global semiconductor industry, has shared new developments regarding its ongoing common share repurchase program. This initiative, showcasing the firm's commitment to returning value to shareholders, was first articulated in previous communications, particularly in a release update issued earlier.

Details on the Repurchase Program

The current repurchase program has been tactically planned and approved by both shareholder resolutions and the supervisory board. With a keen focus on supporting its stock value, STMicroelectronics initiated a series of transactions in a designated period. The recent activities recorded between March 3 and March 7, 2025, have seen the Company repurchase a considerable number of shares.

Transaction Summary

During this latest phase, STMicroelectronics executed the repurchase of 427,820 ordinary shares, equating to around 0.05% of its issued share capital. The weighted average price during these transactions was approximately EUR 22.9028, culminating in a total financial outlay of EUR 9,798,288.62.

Purpose of Repurchase

These share buybacks are strategically positioned to meet obligations arising from various share option schemes directed at employees and members of management. Such movements are also reflective of the Company’s intention to strengthen its equity structure and reinforce confidence among its stakeholders.

Transactions Breakdown

Throughout the outlined period, STMicroelectronics achieved significant transactions. The repurchases were executed consistently, with a mix of pricing that showcases market adaptability. For example, on March 3, the Company acquired nearly 99,820 shares at EUR 23.5799 per share, while a much larger transaction on March 4 saw 169,000 shares acquired at EUR 22.4299 each.

Comprehensive Total for the Period

Notably, by the conclusion of this active share repurchase phase, STMicroelectronics boosted its treasury stock to a total of 16,454,331 shares, representing about 1.8% of its overall issued share capital. This significant accumulation underscores the Company's proactive stance towards capital management and shareholder engagement.

Future Considerations and Commitment

As the market continues to evolve, STMicroelectronics remains committed to executing its share repurchase strategy in a manner that aligns with its broader financial goals and shareholder interests. The Company anticipates further opportunities to engage in the buyback process should market conditions remain favorable.

About STMicroelectronics

With a team of over 50,000 professionals globally, STMicroelectronics is at the forefront of semiconductor technology. As an integrated device manufacturer, it collaborates with more than 200,000 customers to develop innovative solutions tailored to meet diverse industry needs. The Company's commitment to sustainability is documented, aiming for carbon neutrality and 100% renewable electricity sourcing by the end of 2027, thus positioning itself as a leader in responsible manufacturing.

Frequently Asked Questions

What is the main objective of the share repurchase program?

The main goal is to return value to shareholders and fulfill obligations related to employee share options, enhancing equity credibility.

How many shares have been repurchased in the recent transactions?

Recently, STMicroelectronics repurchased 427,820 ordinary shares within a designated trading period.

What has been the total expenditure on the share repurchase program?

The total amount spent on the recent repurchases amounts to EUR 9,798,288.62.

What percentage of shares does the treasury stock represent now?

Currently, the treasury stock represents approximately 1.8% of STMicroelectronics’ issued share capital.

How does STMicroelectronics plan to utilize the repurchased shares?

The repurchased shares may be held in treasury for employee programs or used for other lawful purposes in future strategic moves.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 64

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 187

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 93

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 617

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 103

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 128

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Rathbones Group's Current Position in Renewi Plc

Updated Category News Views 190

Key Information Overview The disclosure notice from Rathbones Group Plc reflects its significant stake in Renewi Plc, which comprises £1 ordinary shares. This transparency is essential for investors looking to understand potential influences on the market. Discloser Details Rathbones Group Plc has publicly announced their holdings, demonstrating accountability and...

Continue Reading
Waystar Achieves Top Recognition for Healthcare Payments Innovation

Updated Category News Views 191

Waystar's Innovative Solutions Lead to Industry Recognition Waystar has gained significant accolades, being recognized as a leading healthcare payments software platform. This acknowledgment highlights the unique value Waystar brings to the healthcare industry, particularly in addressing nearly half a trillion dollars in administrative waste. Commitment to Combatting...

Continue Reading
Edible Garden Achieves Nasdaq Compliance Milestone for Investors

Updated Category News Views 125

Edible Garden Regains Nasdaq Compliance Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW) has exciting news to share with its investors. Recently, Edible Garden announced that it has successfully regained compliance with the minimum bid price requirement set forth by Nasdaq, a significant achievement that reinforces the...

Continue Reading
Landsbankinn hf. Successfully Concludes Recent Covered Bond Auction

Updated Category News Views 212

Landsbankinn hf. Completes a Successful Covered Bond Auction Landsbankinn hf., a prominent financial institution in Iceland, has recently concluded a successful covered bond auction, showcasing strong investor interest. The auction attracted bids with yields ranging from 7.29% to 3.70%, reflecting competitive terms for investors. Details of the Auction During this event,...

Continue Reading
Investors of Skye Bioscience, Inc. Urged to Seek Legal Support

Updated Category News Views 267

Join the Fight for Justice with Skye Bioscience, Inc. In today's fast-paced financial world, investors need to stay informed and proactive. This is especially true for those who invested in Skye Bioscience, Inc. (NASDAQ: SKYE). As recent developments unfold, it is essential for investors to understand the legal landscape and their rights regarding their investments. The...

Continue Reading